Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Insmed (INSM) Accumulated Depreciation & Amortization (2016 - 2026)

Insmed's Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $63.6 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 21.73% to $63.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $63.6 million through Mar 2026, up 21.73% year-over-year, with the annual reading at $60.8 million for FY2025, 20.77% up from the prior year.
  • Accumulated Depreciation & Amortization came in at $63.6 million for Q1 2026, up from $60.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $63.6 million in Q1 2026 to a low of $5.3 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $46.0 million (2024), against an average of $43.1 million.
  • Year-over-year, Accumulated Depreciation & Amortization plummeted 41.76% in 2022 and then surged 814.65% in 2024.
  • Insmed's Accumulated Depreciation & Amortization stood at $5.3 million in 2022, then increased by 3.77% to $5.5 million in 2023, then soared by 814.65% to $50.3 million in 2024, then increased by 20.77% to $60.8 million in 2025, then grew by 4.67% to $63.6 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Accumulated Depreciation & Amortization are $63.6 million (Q1 2026), $60.8 million (Q4 2025), and $57.2 million (Q3 2025).